Immupharma Share Discussion Threads

[mingbat] 11/1/2018 08:39

It's Walker Crips stockbrokers - nothing to do with potatoes.

[hamhamham1] 11/1/2018 08:38

this rns shows some (or all?) of the options

[hamhamham1] 11/1/2018 08:35

I guess historic share owners are more the people there at the beginning?
A lot of directors (eg Tim) will probably have loads of options accrued over recent years with option to buy at a good rate?

[hamhamham1] 11/1/2018 08:29

Walkers Crisp Group?
I presume this is their pension fund?
Good to see Lloyds, Barclays there.
Lloyds are quite a restrained investor and Barclays are more creative in the market.
A good combo IMHO.

[divinessence] 11/1/2018 08:24

Thanks ham. 35% free float. Three non-exec directors hold approx. 160K. I am sure some pi's here hold more especially those who have been topping up for a while.

[hamhamham1] 11/1/2018 08:21

I don't suppose anyone keeps a record or has a print screen of ii shareholder holdings levels from a month or two ago - or anytime recently?

[hamhamham1] 11/1/2018 07:39

hxxp://www.immupharma.co.uk/aim-rule-26-information/

[hamhamham1] 11/1/2018 07:33

I haven't looked at the ii shareholders for a while, apart from the half a dozen large shareholders I noticed these, are the new or always been there?
(Especially Gary Linnekers favourites)

Lloyds Banking Group 4,257,597 3.21%

Walker Crips group 3,383,869 2.55%

Legal and General Group 3,270,531 2.47%

Barclays Bank 2,848,683 2.15%

[l0ngterm] 10/1/2018 22:00

Spawny: the frightening thing is, it costs on average 1 billion to develop a drug. Including the cost of failures this jumps to 4 billion..Which is a different way of looking at the problem...Hence I can see both sides of the coin here. But do agree way to early to state a final figure never mind 4000p a share.

[dafad] 10/1/2018 21:42

hxxp://www.doctissimo.fr/sante/lupus/traitement-lupus

The below extract is a translation from original version



Recently, Prof. Sylviane Muller and her research team developed a new drug, "Lupuzor", which should be on the market in 2018. "It is an immunomodulatory peptide of the autoreactive immune system that interferes Upstream with T lymphocytes, thus reducing the activation of B-cells generating pathogenic autoantibodies, it does not act as an immunosuppressant, does not affect the entire immune system and has no side effects, "explains Pr. Sylviane Muller. A particularly promising approach.

[spawny100] 10/1/2018 21:40

lol many holders, like myself, a little cynical about some of these predictions will look a bit daft if they do reach some of the wilder numbers proposed. Still I'm more than happy to have as much egg on my face and eat as much humble pie as necessary if I get that wealthy from these!

[luminoso] 10/1/2018 21:27

All we need is moneymaker1 with one of his 60-100 pound a share posts and the Concert party are back in again, to the last man. Happy Days !

[spawny100] 10/1/2018 19:55

He keeps telling us that he will but appears not to be a man of his word ;->

[top tips] 10/1/2018 19:34

njb67 why not shut up until after the results.

[hamhamham1] 10/1/2018 18:35

Well it was just a passing obersvation.
I am happy with the shares I own.

[njb67] 10/1/2018 18:25

ham
it does. Brokers will argue that short selling helps them ensure liquidity in the market and therefore benefits shareholders when they want to buy and sell. I can buy this argument up to a point after which you get into grey areas of potential market manipulation.

GL.

[hamhamham1] 10/1/2018 18:22

It's probably the same.
My head hurts.

[hamhamham1] 10/1/2018 18:20

Am sure stuff goes on all day every day, you just need to know you have the ability to buy to replenish at the end of the day?
I am just a lowly pi :)
hxxps://www.investopedia.com/articles/optioninvestor/09/naked-short-selling.asp

[njb67] 10/1/2018 18:19

ham
how does that differ from my scenario? If there is an agreement in place with a large shareholder prior to selling into the market, then it would essentially be the same situation. The trade data would look the same, small sells that sum to the value of how many shares the large holder is off loading.

Trade data are a bit like tea leaves, if you stare at them long enough, I am sure you can see things. Whether you draw the correct conclusion may be as much down to luck than skill.

[hamhamham1] 10/1/2018 18:17

How about if the broker short sells. They sell shares to pi's they don't own but have an agreement to be able to buy back a lump of shares from the ii at the end of the day to balance the books?